AACC appoints Mark Golden as CEO

By LabPulse.com staff writers

June 12, 2020 -- The American Association for Clinical Chemistry (AACC) has appointed Mark Golden as chief executive officer (CEO), effective August 17.

Golden will be in charge of carrying out a new strategic plan that has five key goals, the AACC said.

  • Building AACC's advocacy programs and influence
  • Driving scientific advancement in laboratory medicine
  • Highlighting the essential value of labs to other healthcare professionals and the public
  • Promoting scientific discussion about and development of data analytics and artificial intelligence
  • Expanding to serve the broader laboratory medicine community

Golden is currently executive director and CEO of the National Society of Professional Engineers, a position he has held for the past seven years.

AACC launches research contest, will award deidentified blood samples
The American Association for Clinical Chemistry (AACC) is set to award large sets of deidentified blood samples to lab medicine teams who demonstrate...
AACC guidance urges caution on rapid POC coronavirus tests
When using rapid point-of-care (POC) tests for the novel coronavirus, healthcare institutions need to monitor the proficiency of operators and make sure...
AACC asks U.S. Senate to prioritize COVID-19 testing
The American Association for Clinical Chemistry (AACC) has sent a letter to U.S. Senate leadership with five recommendations to improve testing for the...
AACC provides a steer on antibody testing for novel coronavirus
The American Association for Clinical Chemistry (AACC) is advising that antibody testing for the novel coronavirus should be limited to diagnostics that...

Copyright © 2020 LabPulse.com

Last Updated ls 6/12/2020 4:20:58 PM